Ginkgo Bioworks Holdings, Inc.
DNA
$10.76
-$0.43-3.84%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 473.69M | 516.92M | 561.57M | 616.21M | 730.37M |
Total Receivables | 23.13M | 27.17M | 22.44M | 24.47M | 29.83M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 15.26M | 12.50M | 12.89M | 18.95M | 20.81M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 10.95M | 7.94M | 5.84M | 2.86M | 2.35M |
Total Current Assets | 523.03M | 564.53M | 602.74M | 662.48M | 783.36M |
|
|||||
Total Current Assets | 523.03M | 564.53M | 602.74M | 662.48M | 783.36M |
Net Property, Plant & Equipment | 562.15M | 581.22M | 598.16M | 616.95M | 628.59M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 66.15M | 68.76M | 72.51M | 79.57M | 90.60M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 47.02M | 46.78M | 55.34M | 59.79M | 60.21M |
Total Assets | 1.23B | 1.29B | 1.38B | 1.48B | 1.63B |
|
|||||
Total Accounts Payable | 11.20M | 11.27M | 14.17M | 15.70M | 23.03M |
Total Accrued Expenses | 51.79M | 65.31M | 19.19M | 65.54M | 101.17M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | 28.97M | -- | -- |
Total Finance Division Other Current Liabilities | 33.73M | 39.09M | 44.94M | 33.19M | 41.96M |
Total Other Current Liabilities | 33.73M | 39.09M | 44.94M | 33.19M | 41.96M |
Total Current Liabilities | 96.72M | 115.67M | 107.27M | 114.43M | 166.15M |
|
|||||
Total Current Liabilities | 96.72M | 115.67M | 107.27M | 114.43M | 166.15M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 428.83M | 434.56M | 438.79M | 445.59M | 452.27M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 92.51M | 95.81M | 115.33M | 122.92M | 173.76M |
Total Liabilities | 618.06M | 646.04M | 661.39M | 682.94M | 792.18M |
|
|||||
Common Stock & APIC | 6.60B | 6.58B | 6.56B | 6.53B | 6.51B |
Retained Earnings | -5.99B | -5.93B | -5.84B | -5.73B | -5.67B |
Treasury Stock & Other | 1.65M | -850.00K | -1.81M | 263.00K | -1.72M |
Total Common Equity | 612.95M | 647.43M | 716.06M | 797.94M | 833.07M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 612.95M | 647.43M | 716.06M | 797.94M | 833.07M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 612.95M | 647.43M | 716.06M | 797.94M | 833.07M |
|